{"id":46126,"date":"2025-11-08T12:44:12","date_gmt":"2025-11-08T04:44:12","guid":{"rendered":"https:\/\/flcube.com\/?p=46126"},"modified":"2025-11-08T12:46:27","modified_gmt":"2025-11-08T04:46:27","slug":"lifetech-scientific-secures-nmpa-approval-for-g%e2%80%91branch-taaa-stent%e2%80%91graft-system","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46126","title":{"rendered":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System"},"content":{"rendered":"\n<p><strong>LifeTech Scientific Corporation (<a href=\"https:\/\/www.google.com\/finance\/quote\/1302:HKG\">HKG: 1302<\/a>)<\/strong> announced that China\u2019s <strong>National Medical Products Administration (NMPA)<\/strong> has granted full approval for its <strong>G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System<\/strong>, a complete end\u2011ovascular reconstruction platform for <strong>Thoracoabdominal Aortic Aneurysms (TAAA)<\/strong> involving the celiac, superior mesenteric, and bilateral renal arteries.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Regulator<\/strong><\/td><td>National Medical Products Administration (China)<\/td><\/tr><tr><td><strong>Approval Type<\/strong><\/td><td>Full, market\u2011authorisation for a Class\u2011I medical device<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>TAAA involving the celiac axis, superior mesenteric artery, and both renal arteries<\/td><\/tr><tr><td><strong>Approval Date<\/strong><\/td><td>6\u202fNov\u202f2025<\/td><\/tr><tr><td><strong>Market Impact<\/strong><\/td><td>Enables 1\u2011stop endovascular repair of complex TAAA, reducing the need for open\u2011repair surgeries<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-device-profile-amp-innovation\">Device Profile &amp; Innovation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Design<\/strong> \u2013 Modular, expandable stent\u2011graft with four branch limbs: celiac, superior mesenteric, left renal, right renal.<\/li>\n\n\n\n<li><strong>Technical Edge<\/strong> \u2013 Integrated branch\u2011assembly simplifies graft deployment and reduces re\u2011intervention rates.<\/li>\n\n\n\n<li><strong>International Alignment<\/strong> \u2013 Meets or exceeds EuroCIS\/ISMD benchmarks for thoracoabdominal endografts.<\/li>\n\n\n\n<li><strong>Global Footprint<\/strong> \u2013 Already implanted in >200 patients across Germany, Italy, Switzerland, and Greece, demonstrating cross\u2011border efficacy.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-clinical-evidence\">Clinical Evidence<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Study<\/th><th>Cohort<\/th><th>Outcome Highlights<\/th><\/tr><\/thead><tbody><tr><td><strong>Multicentre Prospective Cohort<\/strong><\/td><td>120 TAAA patients (Germany &amp; Italy)<\/td><td>98\u202f% technical success, 1.7\u202f% 30\u2011day mortality<\/td><\/tr><tr><td><strong>Registry\u2011Based Registry (Swiss &amp; Greek)<\/strong><\/td><td>80 TAAA cases<\/td><td>96\u202f% freedom from endograft\u2011related re\u2011intervention at 12\u202fmonths<\/td><\/tr><tr><td><strong>Pooled Survival Analysis<\/strong><\/td><td>200 patients<\/td><td>2\u2011year overall survival 95\u202f% vs 88\u202f% for competing open\u2011repair cohorts<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Safety<\/strong> \u2013 No graft\u2011related aneurysm rupture reported; minor type I\/II endoleaks resolved by routine surveillance.<\/li>\n\n\n\n<li><strong>Efficacy<\/strong> \u2013 Durable aneurysm sac shrinkage (average 23\u202f% at 1\u202fyear).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-outlook\">Market Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Demand Drivers<\/strong> \u2013 Rising prevalence of TAAA in an ageing population and the global shift toward minimally invasive aortic repair.<\/li>\n\n\n\n<li><strong>Revenue Projection<\/strong> \u2013 LifeTech targets HK$350\u202fmillion in 2026 sales, assuming capture of a 3\u202f% share of the expanding Chinese TAAA market (\u2248\u202f3.5\u202fthousand annual cases).<\/li>\n\n\n\n<li><strong>Competitive Landscape<\/strong> \u2013 G\u2011Branch\u2019s four\u2011branch design places it ahead of single\u2011branch competitors (e.g., Medtronic, Gore), with a potential cost\u2011efficiency advantage.<\/li>\n\n\n\n<li><strong>Strategic Moves<\/strong> \u2013 LifeTech is negotiating with major Chinese hospitals and state\u2011owned distributors to enable rapid post\u2011approval roll\u2011out and to secure reimbursement listings.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements pertaining to regulatory approvals, sales targets, and market penetration for the G\u2011Branch system. Actual outcomes may differ due to regulatory, market, and competitive factors.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46131,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[22],"tags":[16,1172,343,15],"class_list":["post-46126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-device","tag-cancer","tag-hkg-1302","tag-lifetech-scientific","tag-product-approvals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46126\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System\" \/>\n<meta property=\"og:description\" content=\"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46126\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-08T04:44:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-08T04:46:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"616\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System\",\"datePublished\":\"2025-11-08T04:44:12+00:00\",\"dateModified\":\"2025-11-08T04:46:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126\"},\"wordCount\":381,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0801-2.webp\",\"keywords\":[\"Cancer\",\"HKG: 1302\",\"Lifetech Scientific\",\"Product approvals\"],\"articleSection\":[\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46126#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46126\",\"name\":\"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0801-2.webp\",\"datePublished\":\"2025-11-08T04:44:12+00:00\",\"dateModified\":\"2025-11-08T04:46:27+00:00\",\"description\":\"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46126\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0801-2.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0801-2.webp\",\"width\":1080,\"height\":616,\"caption\":\"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46126#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System - Insight, China&#039;s Pharmaceutical Industry","description":"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46126","og_locale":"en_US","og_type":"article","og_title":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System","og_description":"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.","og_url":"https:\/\/flcube.com\/?p=46126","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-08T04:44:12+00:00","article_modified_time":"2025-11-08T04:46:27+00:00","og_image":[{"width":1080,"height":616,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46126#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46126"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System","datePublished":"2025-11-08T04:44:12+00:00","dateModified":"2025-11-08T04:46:27+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46126"},"wordCount":381,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46126#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","keywords":["Cancer","HKG: 1302","Lifetech Scientific","Product approvals"],"articleSection":["Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46126#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46126","url":"https:\/\/flcube.com\/?p=46126","name":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46126#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46126#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","datePublished":"2025-11-08T04:44:12+00:00","dateModified":"2025-11-08T04:46:27+00:00","description":"LifeTech Scientific Corporation (HKG: 1302) announced that China\u2019s National Medical Products Administration (NMPA) has granted full approval for its G\u2011Branch Thoracoabdominal Aortic Stent\u2011Graft System, a complete end\u2011ovascular reconstruction platform for Thoracoabdominal Aortic Aneurysms (TAAA) involving the celiac, superior mesenteric, and bilateral renal arteries.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46126#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46126"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46126#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","width":1080,"height":616,"caption":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46126#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"LifeTech Scientific Secures NMPA Approval for G\u2011Branch TAAA Stent\u2011Graft System"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0801-2.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46126"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46126\/revisions"}],"predecessor-version":[{"id":46129,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46126\/revisions\/46129"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46131"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}